Zentrela logo

Neurotech Start-Up Zentrela Announces $850K in Seed Funding to Build the World’s Largest Scientific Database of Cannabis Product Effects

[ale_divider style=”thin” text=”notext”] Divider Text [/ale_divider]

This article appeared on newswire.ca. To read the original post Click Here.

[ale_divider style=”thin” text=”notext”] Divider Text [/ale_divider]

HAMILTON, ONFeb. 11, 2021 /CNW/ – Canadian neurotech start-up Zentrela today announced the completion of an $850K seed round led by Jornic Ventures.

The investment will be used to further commercialize Zentrela’s proprietary EEG test for cannabis impairment and create the world’s largest scientific database of cannabis product effects1. In 2019 the company raised $1.2M in funding from the Ontario Brain Institute and various government agencies to fund prototype development and clinical trials.

The neuroscience of cannabis is advancing quickly at pace with the speed of deregulation, as government regulators, license producers, drug testing experts, law enforcement officials and recreational cannabis users seek to better understand cannabis and its effects on the brain.

“Our research has already identified several proprietary signatures related to how cannabis impacts the brain. We are now cataloguing the entire universe of effects for Cannabis 2.0 products. This goldmine of data will help unlock new insights and opportunities for licensed producers and enable cannabis consumers to make more informed purchase decisions to ensure responsible and enjoyable cannabis use,” says Israel Gasperin, Zentrela CEO and founder.

“We expect innovative cannabis 2.0 products will trigger the next wave of growth in the cannabis sector, especially as US markets continue to deregulate and the prospect of national US legalization becomes more real,” says Richard Sansom, President of Jornic Ventures. “Zentrela’s unique and scalable neuroscience-based methodology solves a major challenge for the industry and promises to provide a rapidly growing universe of cannabis users with the information they demand and need safe and enjoyable cannabis use.”

Zentrela’s approach combines proprietary artificial intelligence algorithms with deep neuroscience expertise to decode electrical brain activity and convert it into reliable and meaningful information.

“The potential for neuroscience has exploded as artificial intelligence and machine learning algorithms have matured. We can now isolate neural ‘signatures’ of product effects and use that information rapidly to accelerate the process of mapping specific cannabis product effects for consumers,” says Gasperin.

About Zentrela

Zentrela Inc. is advancing the understanding of the brain effects of recreational cannabis and is creating the world’s largest scientific database of cannabis product effects. Visit us at http://www.zentrela.com

About Jornic Ventures

Jornic Ventures partners with aspiring entrepreneurs who’ve set out to bring important ideas to life. Founded in 1995, our Calgary based firm, comprising venture capital, project finance, and private equity invests early to accelerate innovation in technology, food and agriculture, energy, and real estate.

Company Social Links
Linkedin https://www.linkedin.com/company/zentrela-inc/ 
Facebook https://www.facebook.com/ZentrelaInc
Twitter https://twitter.com/ZentrelaInc

SOURCE Zentrela Inc.

Share this article
Facebook
Twitter
LinkedIn
WhatsApp
Email
View All Categories

Featured iF Clients

A 6-week training & mentorship program that offers startups and growing businesses opportunities to build strategic connections, and prepare to secure investment capital.

Ready to accelerate your business growth?

Founders Fast Track is 6 week mentorship program that provides your startup with access to industry expertise, resources, networking opportunities, and skills to help you secure investment capital.

Applications are open until April 14, 2024

Synapse Life Science Pitch Competition

Get tickets for the 2024 Synapse Competition!

Innovation Factory’s Synapse Competition is Ontario’s premier life science pitch competition, dedicated to fostering innovation in the life science sector.

Why you should attend:

  • Meet the finalists at the 11th annual Synapse Competition showcase!
  • Discover emerging life science innovations
  • Network with industry leaders and a thriving life science ecosystem.

March 20, 2024 | 4:00pm – 8:00pm EDT